India Oxcarbazepine Market to grow at a steady rate During the Forecast Period
Growing cases of epilepsy in
the country is expected to drive the growth of India oxcarbazepine market
during the forecast period.
According
to TechSci Research report, “India Oxcarbazepine Market By Source (In-house v/s
Contract Manufacturing Organizations), By Form (Tablet v/s Oral Suspension), By
Distribution Channel (Online v/s Offline), By Application (Epilepsy, Neuropathic
Pain, Seizures and Others), By End User (Adult v/s Paediatric), By Company, By
Region, Forecast & Opportunities, FY2027”, the India oxcarbazepine market is expected to grow at a
steady rate during the forecast period. The medication alone is very effective
in treating partial seizures in children of 4 years and older which is expected
to fuel the market growth through FY2027. Also, this drug is used in
combination with other medications to treat partial seizures in children of 2
years old and above by inhibiting abnormal electrical activity in the brain. However,
side-effects associated with drug consumption such as nausea, vomiting, double
vision, dizziness, drowsiness and trouble with walking can restrict the market
growth over the next few years. Moreover, in some severe cases, side effects such
as liver problems, anaphylaxis, pancreatitis and an abnormal heartbeat. can
occur. This can further reduce the usage and application of the drug thereby
hindering the market growth during the forecast period.
Browse XX market data Tables and XX Figures spread
through XXX Pages and an in-depth TOC on
" India Oxcarbazepine Market"
https://www.techsciresearch.com/report/india-oxcarbazepine-market/7312.html
The India oxcarbazepine market is segmented based on source, form, distribution channel,
application, end user, company, and region. Based on end user, the market
can be fragmented into adult v/s pediatric. The adult segment dominated the
market until FY2020 and is further forecasted to maintain its dominance during
the forecast period as well. This dominance can be accredited to the wide use
of oxcarbazepine in adults to treat epilepsy, as this condition is most
commonly diagnosed in people over 65 years of age. The pediatric segment is
expected to grow at a high CAGR in the market during forthcoming years on
account of rising epileptic condition in people under 20. The most common
conditions for epilepsy in children includes difficulties at their birth,
childhood infections or accidents. Based on application, the market can be
categorized into epilepsy, neuropathic pain, seizures and others. The epilepsy segment
dominated the market until FY2020 due to rising prevalence of epilepsy in the
country. Neuropathic pain application segment is forecasted to witness high
growth in the next 5 years which can be accredited to effectiveness of this
drug in treating this condition.
Sun Pharmaceuticals Industries
Ltd., Intas Pharmaceutical Ltd., Sunrise Remedies Pvt. Ltd., Cipla Limited,
Zydus Cadila Healthcare Ltd., Nicholas Piramal India Ltd., Torrent
Pharmaceuticals Ltd., Macleods Pharmaceuticals Ltd., Consern Pharma Pvt. Ltd., Glenmark Lifesciences Ltd. and
others are some of the leading players operating in India oxcarbazepine market.
Companies operating in the market are using strategies such as product
launches, mergers and acquisitions and research collaborations to boost their
share and increase their geographic reach.
Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=7312
Customers can also
request for 10% free customization on this report.
“India oxcarbazepine market is expected
to witness growth during the forecast period as it is used to treat patients
with bipolar disorders. In addition to this, oxcarbazepine has a reduced
propensity for involvement in drug-drug interactions when compared to other
anti-epileptic drugs which can be attributed to its primarily reductive
metabolism, causing less side effects. This is further expected to create
lucrative opportunities for the market growth of India oxcarbazepine market
over the next five years.” said Mr. Karan Chechi, Research Director with
TechSci Research, a research based India management consulting firm.
“India Oxcarbazepine Market By Source (In-house v/s
Contract Manufacturing Organizations), By Form (Tablet v/s Oral Suspension), By
Distribution Channel (Online v/s Offline), By Application (Epilepsy,
Neuropathic Pain, Seizures and Others), By End User (Adult v/s Paediatric), By
Company, By Region, Forecast & Opportunities, FY2027”, has evaluated the future growth potential of India oxcarbazepine
market and provides statistics & information on market size, structure and
future market growth. The report intends to provide cutting-edge market
intelligence and help decision makers take sound investment decisions. Besides,
the report also identifies and analyzes the emerging trends along with
essential drivers, challenges and opportunities in India oxcarbazepine market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]
Web: https://www.techsciresearch.com/